|
Volumn 25, Issue 16, 2015, Pages 3295-3300
|
Novel (pyrazolyl)benzenesulfonamides with a nitric oxide-releasing moiety as selective cyclooxygenase-2 inhibitors
|
Author keywords
Anti inflammatory therapy; Cardiovascular side effects; Celecoxib; Direct indirect NO coupling; Griess assay; Organic nitrate
|
Indexed keywords
(PYRAZOLYL)BENZENESULFONAMIDE DERIVATIVE;
4 [3 (HYDROXYMETHYL) 5 (PARA TOLYL) 1H PYRAZOL 1 YL]BENZENESULFONAMIDE;
ANTIINFLAMMATORY AGENT;
BENZENESULFONAMIDE DERIVATIVE;
CELECOXIB;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
DICHLORINATED CHLORO [3 (CHLOROMETHYL) 5 (PARA TOLYL) 1H PYRAZOL 1 YL]BENZENESULFONAMIDE;
MONOCHLORINATED 4 [3 (CHLOROMETHYL) 5 (PARA TOLYL) 1H PYRAZOL 1 YL]BENZENESULFONAMIDE;
NITRIC OXIDE DONOR;
ORGANIC NITRATE;
UNCLASSIFIED DRUG;
[1 (4 SULFAMOYLPHENYL) 5 (PARA TOLYL) 1H PYRAZOL 3 YL]METHYL NITRATE;
[4 CHLORO 1 (4 SULFAMOLYPHENYL) 5 (PARA TOLYL) 1H PYRAZOL 3 YL]METHYL NITRATE;
BENZENESULFONAMIDE;
NITRIC OXIDE;
NONSTEROID ANTIINFLAMMATORY AGENT;
SULFONAMIDE;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
CHEMICAL STRUCTURE;
CHLORINATION;
HUMAN;
IC50;
CARDIOVASCULAR DISEASE;
CHEMICALLY INDUCED;
CHEMISTRY;
DRUG EFFECTS;
ENZYME ACTIVATION;
METABOLISM;
SYNTHESIS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CARDIOVASCULAR DISEASES;
CYCLOOXYGENASE 2 INHIBITORS;
ENZYME ACTIVATION;
HUMANS;
INHIBITORY CONCENTRATION 50;
MOLECULAR STRUCTURE;
NITRIC OXIDE;
SULFONAMIDES;
|
EID: 84934844110
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2015.05.059 Document Type: Article |
Times cited : (22)
|
References (31)
|